Core_Unicon

Why Pharma's Capital Expansion Boom Is Creating a CQV Supercycle Biopharma is entering one of the most consequential transformation cycles in its history. Across the globe, companies are building new manufacturing facilities at unprecedented speed—facilities designed not merely to expand capacity, but to keep pace with fundamental shifts in science, global supply chain dynamics, and rising regulatory expectations. This surge of investment in biologics, mRNA, and cell and gene therapy...

In the life sciences industry, remediation is a critical process for addressing and correcting non-compliance issues, quality defects,...